148 related articles for article (PubMed ID: 8785584)
1. Proceedings of the third international workshop on scleroderma research.
Black CM; Korn JH
Matrix Biol; 1995 Dec; 14(9):699-704. PubMed ID: 8785584
[No Abstract] [Full Text] [Related]
2. The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?
Yamamoto T
Arch Dermatol Res; 2006 Feb; 297(8):333-44. PubMed ID: 16402183
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue metabolism including cytokines.
Amento EP
Curr Opin Rheumatol; 1989 Dec; 1(4):485-9. PubMed ID: 2702050
[No Abstract] [Full Text] [Related]
4. Oncogenes, growth factors, and matrix in the pathogenesis of systemic sclerosis.
Gay S; Boulware DW; Gay RE
Clin Dermatol; 1994; 12(3):419-24. PubMed ID: 7954199
[No Abstract] [Full Text] [Related]
5. The control of fibrosis in systemic sclerosis: a strategy involving extracellular matrix, cytokines, and growth factors.
LeRoy EC
J Dermatol; 1994 Jan; 21(1):1-4. PubMed ID: 8157815
[No Abstract] [Full Text] [Related]
6. The Second International Workshop on Scleroderma Research.
Korn JH; Black C
Matrix; 1993 Sep; 13(5):427-9. PubMed ID: 8246838
[No Abstract] [Full Text] [Related]
7. Growth factors, extracellular matrix, and oncogenes in scleroderma.
Gay S; Trabandt A; Moreland LW; Gay RE
Arthritis Rheum; 1992 Mar; 35(3):304-10. PubMed ID: 1536668
[No Abstract] [Full Text] [Related]
8. Sixth international workshop on scleroderma research, Oxford, UK, 30 July--22 August 2000.
Wollheim FA; Denton CP; Abraham DJ
Arthritis Res; 2001; 3(1):34-40. PubMed ID: 11269238
[TBL] [Abstract][Full Text] [Related]
9. Systemic sclerosis up to date.
Takehara K
J Dermatol; 2010 Jan; 37(1):2. PubMed ID: 20175835
[No Abstract] [Full Text] [Related]
10. Pathogenesis of scleroderma. Collagen.
Jimenez SA; Hitraya E; Varga J
Rheum Dis Clin North Am; 1996 Nov; 22(4):647-74. PubMed ID: 8923589
[TBL] [Abstract][Full Text] [Related]
11. Systemic sclerosis.
Asano Y
J Dermatol; 2018 Feb; 45(2):128-138. PubMed ID: 29226387
[TBL] [Abstract][Full Text] [Related]
12. Scleroderma.
Gilliam AC
Curr Dir Autoimmun; 2008; 10():258-79. PubMed ID: 18460891
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of urokinase-type plasminogen activator receptor (uPAR) gene induces dermal and pulmonary fibrosis and peripheral microvasculopathy in mice: a new model of experimental scleroderma?
Manetti M; Rosa I; Milia AF; Guiducci S; Carmeliet P; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2014 Sep; 73(9):1700-9. PubMed ID: 23852693
[TBL] [Abstract][Full Text] [Related]
14. [Systemic sclerosis: pathophysiology of a multifaceted disease].
Servettaz A; Agard C; Tamby MC; Guilpain P; Guillevin L; Mouthon L
Presse Med; 2006 Dec; 35(12 Pt 2):1903-15. PubMed ID: 17159716
[TBL] [Abstract][Full Text] [Related]
15. The microvascular endothelium in scleroderma.
Kahaleh B
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v14-5. PubMed ID: 18784128
[TBL] [Abstract][Full Text] [Related]
16. Control of fibrosis in systemic scleroderma.
Mauch C; Eckes B; Hunzelmann N; Oono T; Kozlowska E; Krieg T
J Invest Dermatol; 1993 Jan; 100(1):92S-96S. PubMed ID: 8423407
[TBL] [Abstract][Full Text] [Related]
17. The vascular perspective of systemic sclerosis: of chickens, mice and men.
Sgonc R
Int Arch Allergy Immunol; 1999 Nov; 120(3):169-76. PubMed ID: 10592461
[TBL] [Abstract][Full Text] [Related]
18. Scleroderma -- news to tell.
Eckes B; Hunzelmann N; Moinzadeh P; Krieg T
Arch Dermatol Res; 2007 Jun; 299(3):139-44. PubMed ID: 17453220
[TBL] [Abstract][Full Text] [Related]
19. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
[TBL] [Abstract][Full Text] [Related]
20. Cytokines and human fibrosis.
LeRoy EC; Trojanowska MI; Smith EA
Eur Cytokine Netw; 1990; 1(4):215-9. PubMed ID: 1966552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
